Significant gynecological bleeding in women with low von Willebrand factor levels by Michelle Lavin, Sonia Aguila, Niall Dalton, Margaret Nolan, Mary Byrne,

Slides:



Advertisements
Similar presentations
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival by Sandra L. Haberichter,
Advertisements

Molecular Genetics in the Von Willebrand disease Ghasem Rastegarlari.
Von Willebrand’s Disease (vWD) Among women with unexplained menorrhagia.
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation by Surbhi Shah, Faye L. Norby, Yvonne.
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study by Pier M. Mannucci,
MBL: mostly benign lymphocytes, but…
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
by Nataliya Melnyk, and Jonathan Harrison
Bleeding in carriers of hemophilia
Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia by Teresa Padró, Sandra Ruiz, Ralf Bieker, Horst Bürger, Martin Steins,
Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura by Evaren E. Page, Johanna A. Kremer.
Reproductive capacity in iron overloaded women with thalassemia major
Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,
Thrombin generation: biochemical possibilities and clinical reality
by Adrienne Lee, Steven K. Boyd, Gregory Kline, and Man-Chiu Poon
by James D. Cook, Carol H. Flowers, and Barry S. Skikne
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Total-Thrombus-Formation Analysis System Using a Microchip Flow Chamber Reflects Bleeding Severity of Patients with Type 1 Von Willebrand Disease. by Kenichi.
Blocking VWF platelet binding to treat TTP
by Jon E. Arnason, Federico Campigotto, Donna Neuberg, and James B
Plasma active glucagon-like peptide-1 (GLP-1) response in patients with type  2 diabetes during the liquid high-fat meal test at baseline, 12 weeks and.
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor by Anne F. Riddell,
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma by Pier Luigi Zinzani, Vincent.
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD by Nelli Bejanyan, Claudio G. Brunstein,
by Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, and Akihiro Hisaka
Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal.
Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea by Françoise Bernaudin, Cécile Arnaud,
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA by Nikola P. Konstandin, Friederike Pastore, Tobias Herold, Annika Dufour,
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors by Manu T. Kalathottukaren, A.
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency by Gillian N. Gidley, Lori A. Holle,
by Dana T. Lounder, Qiong Bin, Cristina de Min, and Michael B. Jordan
The common VWF single nucleotide variants c. 2365A>G and c
by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
Reduced red blood cell deformability in Plasmodium knowlesi malaria
Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease by Margaret T. Lee, Meyer Kattan,
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.
Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome by Yoko Yoshida, Masanori Matsumoto,
by Nicholas J. Laping, Michael P. DeMartino, Joshua E
Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR by Duncan Murray, Jack Luke McMurray,
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma by Sham Mailankody, Dickran Kazandjian, Neha Korde,
Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.
Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.
by Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F
Plasma biomarker concentrations between study groups.
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity by Ruqayyah J. Almizraq, Philip J. Norris, Heather.
Translational efficiency of ATM, MRN complex, and RIF1.
by Jens Kjeldsen-Kragh, Thomas L
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis by Samuel Yamshon,
Kinetics of clone appearance, size, persistence, and lineage content.
by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry by Donald M. Arnold, Ishac Nazy, Rumi.
Sara C. Meyer, Alix O’Meara, Andreas S. Buser, André Tichelli, Jakob R
Oral glucose tolerance testing during hospitalization and at 4 months after infarction. Oral glucose tolerance testing during hospitalization and at 4 months.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor.
by Andrew L. Gilman, Michael J
Scatter and box plot of midpoint measurement compared with age of subject. Scatter and box plot of midpoint measurement compared with age of subject. The.
by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio
Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib by Chung H. Kok, David T.
Change in FES uptake in the tumor during fulvestrant treatment.
External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation by Roni Shouval, Joshua A. Fein,
Baseline and 1-month data for the abstinence group presented as pre/post scatter plot (left) and bar chart chart (right). Bar chart data are presented.
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients by Elena.
Balancing bleeding in brain metastases
Two to 20 years: female patients, continued.
Presentation transcript:

Significant gynecological bleeding in women with low von Willebrand factor levels by Michelle Lavin, Sonia Aguila, Niall Dalton, Margaret Nolan, Mary Byrne, Kevin Ryan, Barry White, Niamh M. O’Connell, Jamie M. O’Sullivan, Jorge Di Paola, Paula D. James, and James S. O’Donnell BloodAdv Volume 2(14):1784-1791 July 24, 2018 © 2018 by The American Society of Hematology

Michelle Lavin et al. Blood Adv 2018;2:1784-1791 © 2018 by The American Society of Hematology

Philipps score and menorrhagia bleeding scores in women with low VWF Philipps score and menorrhagia bleeding scores in women with low VWF. (A) Bar chart of the number of women with positive responses to the 4 domains included in the Philipps tool. Philipps score and menorrhagia bleeding scores in women with low VWF. (A) Bar chart of the number of women with positive responses to the 4 domains included in the Philipps tool. (B) Comparison of the ISTH BAT and Condensed MCMDM-1 VWD menorrhagia-domain score in women with low VWF using identical clinical information (median 3 vs 2, P < .0001, median and interquartile range [IQR], indicated for Condensed MCMDM-1 VWD; for the ISTH BAT both the median and IQR are equal to 3). (C-D) Bar chart of menorrhagia-domain bleeding scores by lowest recorded plasma VWF levels. When examined by lowest recorded plasma VWF levels, 84% of those female enrollees with lowest levels (30-39 IU/dL) had ISTH BAT menorrhagia-domain scores ≥3 in comparison with 67% of patients with lowest plasma VWF level (40-50 IU/dL) (C). A similar pattern was seen using the Condensed MCMDM-1 VWD score (D). Michelle Lavin et al. Blood Adv 2018;2:1784-1791 © 2018 by The American Society of Hematology

Ferritin levels in women with low VWF and pregnancy related changes in plasma VWF levels. Ferritin levels in women with low VWF and pregnancy related changes in plasma VWF levels. (A) Scatter dot plot of lowest recorded ferritin (n = 103) with the median (21.1 μg/L) indicated by the red bar and lower limit of the normal reference range (23.0-393 μg/L) by the dotted line. (B-C) Plasma VWF:Ag levels (B) and VWF:RCo levels (C) at baseline and during pregnancy in a subgroup of 32 women (38 pregnancies). Normal reference range indicated by dotted lines. Michelle Lavin et al. Blood Adv 2018;2:1784-1791 © 2018 by The American Society of Hematology